Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03265912 · ClinicalTrials.gov registry record
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment
A clinical trial, sponsored by ElMindA.
- Completed
- Registry status
- 46
- Enrollment target
NCT03265912: Completed study, sponsored by ElMindA.
NCT03265912 is a clinical trial that has completed, run by ElMindA. The registered enrollment target is 46 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03265912 has completed, sponsored by ElMindA.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
mTBI is widely recognized as a major public health concern in the United States and worldwide. mTBI diagnosis remains a clinical challenge as no single test can diagnose every concussion. Recent advances in EEG evoked response potential analysis have led to a novel technique for assessing brain network activation (BNA) patterns. This study purpose is to study this BNA technology in individuals who have sustained a concussion.
Primary Outcome
Functional networks of brain activity is measured using analysis of EEG Event Related Potential (ERP) data. Clinical assessments battery will be utilized in order to examine different sets of BNA database for Mild Traumatic Brain Injury and Non Mild Traumatic Brain Injury population.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-01-26 |
| Est. Completion | 2018-01-16 |
What the finished NCT03265912 record still lists
NCT03265912 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03265912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03265912 about?
NCT03265912 is a clinical study titled "Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment". mTBI is widely recognized as a major public health concern in the United States and worldwide. mTBI diagnosis remains a clinical challenge as no single test can diagnose every concussion. Recent advances in EEG evoked response potential analysis have led to a novel technique for assessing brain netw...
What is the current status of trial NCT03265912?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2017-01-26. Estimated completion is 2018-01-16.
Who is sponsoring clinical trial NCT03265912?
This trial is sponsored by ElMindA, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI